You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Bulk Pharmaceutical API Sources for STILPHOSTROL


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for STILPHOSTROL

Vendor Vendor Homepage Vendor Sku API Url
AKos Consulting & Solutions ⤷  Get Started Free AKOS005267157 ⤷  Get Started Free
Molport ⤷  Get Started Free MolPort-006-111-609 ⤷  Get Started Free
TimTec ⤷  Get Started Free SBB080783 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Stilphostrol

Last updated: July 29, 2025

Introduction

Stilphostrol, a synthetic non-steroidal estrogen, has historically been used in research and certain clinical applications involving hormone-dependent cancers and reproductive health. Due to its pharmacological profile, its procurement and sourcing are pivotal for pharmaceutical manufacturing, research, and regulatory compliance. As a selective estrogen receptor modulator (SERM), Stilphostrol’s synthesis and sourcing present unique challenges, especially given regulatory scrutiny and the need for high-purity APIs. This article examines the current landscape of bulk API sources for Stilphostrol, analyzing primary suppliers, sourcing strategies, regulatory considerations, and market trends pertinent to industry stakeholders.


Understanding Stilphostrol and Its Market Context

Developed primarily for research purposes, Stilphostrol belongs to a class of non-steroidal estrogens with potential regulatory and clinical oversight. It is structurally related to compounds like diethylstilbestrol (DES), which has a complex legacy due to safety concerns. Although commercial availability is limited compared to mainstream pharmaceuticals, the demand for Stilphostrol from academic, research, and niche pharmaceutical sectors persists. Accordingly, the API sourcing approaches tailored for Stilphostrol focus on ensuring stringent quality control, regulatory compliance, and reliable supply chains.


Primary Sources of Stilphostrol API

  1. Manufacturers Specialized in Custom API Synthesis

    Leading chemical and pharmaceutical contract manufacturing organizations (CMOs) with expertise in complex organic synthesis dominate the supply landscape. These entities often produce Stilphostrol under strict Good Manufacturing Practices (GMP) for targeted clients, especially in research and development phases. Notable companies include:

    • Bachem: A Swiss-based global provider specializing in peptide and small molecule APIs, Bachem offers custom synthesis services, including non-standard compounds like Stilphostrol, with high purity and compliance standards.

    • Auradia Chemicals: An Indian API manufacturer with expertise in estrogenic compounds, Auradia provides custom synthesis and bulk APIs for research and clinical applications. Their capabilities include multi-step synthesis processes and strict quality assurance protocols.

    • Cambridge Isotope Laboratories: While primarily focused on isotopically labeled compounds, this firm also offers custom API synthesis, leveraging their advanced chemistry infrastructure.

  2. Chemical Refineries and Specialty API Producers

    Several regional and international chemical producers operate in niche estrogenic compound manufacturing. Their source of Stilphostrol often stems from bespoke synthesis routes, optimized for purity and yield:

    • Sigma-Aldrich (Merck): Traditionally, Sigma-Aldrich provides research-level Stilphostrol API for laboratory use. However, commercial quantities for clinical development require direct arrangements with the company or affiliates.

    • Tocris Bioscience: Provides research-grade Stilphostrol and related compounds, chiefly for laboratory application in pharmacological research.

  3. Chemical Trade Platforms and Brokers

    Marketplaces like Alibaba, ChemSpider, and other chemical trading platforms list Stilphostrol API, often from secondary suppliers or brokers. While offering rapid access, such sources necessitate rigorous due diligence regarding purity, certification, and regulatory compliance:

    • Consumers must verify supplier credentials, ISO certifications, and safety data sheets comprehensively.
  4. Custom Synthesis and Importation Strategies

    Pharma companies and research institutes often contract specialized synthesis from known API manufacturers or establish partnerships to secure high-quality, bulk Stilphostrol API. These strategies involve:

    • Direct sourcing from GMP-certified manufacturers ensuring compliance with regulatory standards like FDA, EMA, or equivalent.

    • Importation under proper customs and regulatory clearances with necessary documentation, including Certificates of Analysis (CoA) and Good Manufacturing Practice (GMP) certifications.


Regulatory and Quality Considerations

Given Stilphostrol’s pharmacological activity and historical safety concerns, sourcing must comply with stringent regulatory standards if intended for clinical use:

  • GMP Compliance: Suppliers must provide GMP-grade APIs with detailed CoA, indicating batch purity (> 98%) and absence of contaminants.

  • Certifications: Suppliers should hold ISO certifications and validation reports, especially if APIs are used in clinical research or production.

  • Documentation and Traceability: Full documentation ensures traceability, crucial for regulatory audits and quality assurance.

Challenges in Sourcing

  • Limited Commercial Availability: Since Stilphostrol is primarily research-grade, full-scale commercial production might be limited, affecting supply stability.

  • Regulatory Restrictions: Certain jurisdictions impose restrictions on the import, sale, or use of hormonal compounds like Stilphostrol, necessitating careful compliance planning.

  • Pricing and Lead Time: Niche APIs often entail higher costs and longer lead times, especially for GMP-certified batches.


Emerging Trends in API Sourcing for Stilphostrol

  • Increasing Use of Custom Synthesis: With regulatory pressures on drug safety, pharmaceutical companies increasingly seek custom synthesis with transparent quality credentials.

  • Shift Toward Sustainable and Green Chemistry: Green synthesis routes are being explored to minimize environmental impact, although adoption remains limited due to technical complexity.

  • Global Supply Diversification: To mitigate risks, companies source APIs from multiple suppliers across different regions, including North America, Europe, and Asia.

  • Digitalization and Blockchain Traceability: Enhanced traceability systems are improving supply chain transparency, critical for high-value, regulated compounds like Stilphostrol.


Conclusion

The supply chain for bulk Stilphostrol API is specialized and niche, dominated by a handful of custom synthesis providers, chemical brokers, and research suppliers. To ensure compliance, quality, and supply security, organizations should prioritize GMP-certified sources, enforce rigorous quality assessments, and establish strategic partnerships with reputable manufacturers. The dynamic regulatory landscape and the compound's research-focused status require ongoing diligence and adaptability from procurement and compliance teams.


Key Takeaways

  • Sourcing Stilphostrol API predominantly involves specialized custom synthesis from qualified CMOs and research chemical suppliers.
  • Ensuring GMP compliance, rigorous certification, and detailed documentation are critical for regulatory and safety assurance.
  • Market limitations necessitate strategic planning, including diversified sourcing and validation of supplier credentials.
  • Advances in sustainable chemistry and digital tracking are shaping the future landscape of API sourcing for niche compounds like Stilphostrol.
  • Regular monitoring of regulatory updates and supplier certifications ensures ongoing compliance and supply integrity.

FAQs

1. Is Stilphostrol available from major pharmaceutical suppliers?
Stilphostrol is primarily available for research purposes from specialized chemical suppliers. Its commercial availability for pharmaceutical manufacturing is limited and typically requires custom synthesis arrangements with qualified CMOs.

2. What quality standards should I expect from a reputable Stilphostrol API supplier?
Reputable suppliers should provide GMP-certified APIs with a Certificate of Analysis indicating purity above 98%, absence of contaminants, and compliance with regulatory standards such as ISO certifications.

3. How can I verify the authenticity and purity of Stilphostrol purchased from a broker?
Request detailed documentation, including CoA, validation reports, and supplier certifications. Confirm supplier credentials through independent checks or third-party audits whenever possible.

4. Are there regional differences in sourcing Stilphostrol?
Yes, European and North American suppliers tend to adhere to stricter GMP standards, whereas Asian suppliers might offer more competitive pricing but require thorough vetting for compliance and quality assurance.

5. What are the regulatory considerations when importing Stilphostrol API?
Regulatory requirements vary by country. Importers must ensure proper licensing, documentation, and adherence to restrictions on hormonal compounds. Consulting with regulatory experts can prevent legal and compliance issues.


References

  1. European Pharmacopoeia. Estrogenic compounds standards. [European Directorate for the Quality of Medicines & HealthCare, EDQM].
  2. U.S. Food and Drug Administration (FDA). Regulations on hormonal APIs and controlled substances.
  3. Market research reports on niche API suppliers and custom synthesis providers.
  4. Industry news and supplier catalogs from leading chemical suppliers, e.g., Sigma-Aldrich, Bachem.

This comprehensive review serves as an authoritative guide for stakeholders seeking to understand the sourcing landscape for Stilphostrol bulk API, emphasizing quality, compliance, and strategic procurement.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.